Clinical trial for Attention Deficit Hyperactivity Disorder
Official title Neurocognitive Effects of Non-Invasive Near-Infrared Light Stimulation
ClinicalTrials.gov ID: NCT05802680
What this study is testing
- What it's testing
- The study wants to see if shining near‑infrared light on the brain (transcranial photobiomodulation) changes attention performance compared with a fake treatment.
- Who it's for
- Adults who either have ADHD or have normal attention and meet the study’s screening criteria.
- What's involved
- Participants are randomly given either real light or a sham (placebo) light for 8 minutes, then complete a 14‑minute computer test of attention.
- Time commitment
- The whole visit lasts about 30 minutes with a single treatment and testing session.
Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older. Healthy volunteers may be eligible.
You may be able to join if
- 18 years of age or older
You likely can't join if
- None
The study team makes the final eligibility decision.
Where it is enrolling
- Austin, Texas, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Austin, Texas, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.